Cargando…
EMT-independent detection of circulating tumor cells in human blood samples and pre-clinical mouse models of metastasis
Circulating tumor cells (CTCs) present an opportunity to detect/monitor metastasis throughout disease progression. The CellSearch® is currently the only FDA-approved technology for CTC detection in patients. The main limitation of this system is its reliance on epithelial markers for CTC isolation/e...
Autores principales: | Kitz, Jenna, Goodale, David, Postenka, Carl, Lowes, Lori E., Allan, Alison L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882592/ https://www.ncbi.nlm.nih.gov/pubmed/33415568 http://dx.doi.org/10.1007/s10585-020-10070-y |
Ejemplares similares
-
Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis
por: Kitz, Jenna, et al.
Publicado: (2018) -
Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer
por: Lowes, Lori E., et al.
Publicado: (2016) -
Reduced Zeb1 Expression in Prostate Cancer Cells Leads to an Aggressive Partial-EMT Phenotype Associated with Altered Global Methylation Patterns
por: Kitz, Jenna, et al.
Publicado: (2021) -
Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis
por: Beausoleil, Michel S, et al.
Publicado: (2011) -
Triple-Negative Primary Breast Tumors Induce Supportive Premetastatic Changes in the Extracellular Matrix and Soluble Components of the Lung Microenvironment
por: Medeiros, Braeden, et al.
Publicado: (2020)